Related references
Note: Only part of the references are listed.Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis
Yuji Kasukawa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial
Ralf Westenfeld et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus
I. Kanazawa et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases
Akimitsu Miyauchi et al.
BONE (2010)
Vitamins K and D Status in Stages 3-5 Chronic Kidney Disease
Rachel M. Holden et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Carboxylation of Osteocalcin Affects Its Association With Metabolic Parameters in Healthy Children
Anna Prats-Puig et al.
DIABETES CARE (2010)
High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
Masataka Shiraki et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
Pawel Szulc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
Patrick Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Significant Association of Fracture of the Lumbar Spine with Mortality in Female Hemodialysis Patients: A Prospective Observational Study
Yoshifumi Maeno et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Prevalence of chronic kidney disease in the Japanese general population
Enyu Imai et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2009)
Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients
Kaori Shidara et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction
Shinsuke Yamada et al.
CLINICAL ENDOCRINOLOGY (2008)
Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects
Yoshiki Nishizawa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2008)
Subclinical vitamin K deficiency in hemodialysis patients
Rachel M. Pilkey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b
Tatsuya Ohashi et al.
CLINICA CHIMICA ACTA (2007)
Determinants and correlates of serum undercarboxylated osteocalcin
Katharina Nimptsch et al.
ANNALS OF NUTRITION AND METABOLISM (2007)
Osteoporosis and chronic kidney disease
Anca Gal-Moscovici et al.
SEMINARS IN DIALYSIS (2007)
Serum concentrations of cross-linked N-telopeptides of type I collagen: New marker for bone resorption in hemodialysis patients
Y Maeno et al.
CLINICAL CHEMISTRY (2005)
Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients
S Okuno et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients
K Nagasue et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Relationship between age, renal function and bone mineral density in the US population
S Klawansky et al.
OSTEOPOROSIS INTERNATIONAL (2003)
Vitamin K-2 (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis
T Miki et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2003)
Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay
M Takahashi et al.
CLINICA CHIMICA ACTA (2000)
The use of biochemical markers of bone turnover in osteoporosis
PD Delmas et al.
OSTEOPOROSIS INTERNATIONAL (2000)
Diagnosis of osteoporosis: Respective roles of biomarkers and bone density measurements: State of the art
PD Delmas
OSTEOPOROSIS INTERNATIONAL (2000)
Share Paper
